Soluble Interleukin-2 Receptor Levels in Hepatocellular Cancer: a More Sensitive Marker Than Alfa Fetoprotein
- 1 March 1999
- journal article
- research article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 6 (2), 178-185
- https://doi.org/10.1007/s10434-999-0178-1
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Correlation of soluble interleukin-2 receptor levels with severity of chronic hepatitis C virus liver injury and development of hepatocellular cancerSurgery, 1996
- Biphasic changes in serum hepatocyte growth factor after transarterial chemoembolization therapy for hepato-cellular carcinomaCytokine, 1996
- Clinical evaluation of plasma des-?-carboxy prothrombin as a marker protein of hepatocellular carcinoma in patients with tumors of various sizesDigestive Diseases and Sciences, 1993
- Limited hepatic resection for selected cirrhotic patients with hepatocellular or cholangiocellular carcinoma: A prospective studyBritish Journal of Surgery, 1991
- Soluble Interleukin 2 Receptor in Acute Viral Hepatitis and Chronic Liver DiseaseHepatology, 1989
- Clinical features and prognosis of hepatocellular carcinoma with reference to serum alpha-fetoprotein levels. Analysis of 606 patientsCancer, 1989
- Serum levels of soluble tac peptide in acute and chronic hepatitis B virus infectionClinical Immunology and Immunopathology, 1989
- Production of abnormal prothrombin (des-γ-carboxy prothrombin) by hepatocellular carcinomaJournal of Hepatology, 1987
- Alpha‐fetoprotein changes in the course of chronic hepatitis: relation to bridging hepatic necrosis and hepatocellular carcinomaLiver International, 1986
- Screening Methods for Early Detection of Hepatocellular CarcinomaHepatology, 1985